Sudan

Africa

Contents

1. Regulatory Overview
2. Regulatory Pathways

Regulatory Overview

Sudan is regulated by the NMPB (National Medicines and Poisons Board). The country has 1 documented regulatory pathway for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.

Regulatory Authority

NMPB (National Medicines and Poisons Board)

Regulatory Pathways (1)

Sudan MOH Special Import Authorization 45 days

Sudan Ministry of Health special import authorization for unregistered medicines for patients with serious or life-threatening conditions.

Application Form: MOH Sudan Special Import Form

Legal Basis: Regulated

Eligibility: Serious or life-threatening condition with no locally registered alternative

Sudan

ISO Code	`SD`
Region	Africa
Regulatory Authority	NMPB (National Medicines and Poisons Board)
Pathways	1 documented
Drugs Available	0 documented